Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CI · against 588 other Healthcare companies listed in US-listed
Ranked #29 of 589 · scores higher than 95% of peers
Bars: peers in each 10-point band of the valuation score27 peers with a valuation score of 80–89, including CI · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | CI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 8.2% | -4.3% | 95% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 12.4% | -0.8% | 91% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 11.7% | -2.3% | 95% | 20% | |
| Book yieldHigher is better · 587 reported | 54.7% | 25.9% | 77% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 26 | 10.0B USD | 90 | 64 | |
| 26 | 913M USD | 90 | 77 | |
| 29 | 1.8B USD | 89 | 63 | |
| 29 | 1.7B USD | 89 | 77 | |
| 29 | 78.1B USD | 89 | 60 | |
| 32 | 133M USD | 88 | 51 | |
| 32 | 108.6B USD | 88 | 66 | |
| 34 | 97.5B USD | 87 | 67 | |
| 35 | 1.2B USD | 85 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score